Lung Cancer Medicare Access to Precise Testing Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

• Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Energy and Commerce Committee
  House of Representatives
• Ways and Means Committee
  House of Representatives

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• AMERICAN LUNG ASSOCIATION
  for AMERICAN LUNG ASSOCIATION · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• EQUIFAX, INC.
  for EQUIFAX, INC · Georgia · 3rd Quarter 2026 (July 1 - Sep 30)
• EQUIFAX, INC.
  for EQUIFAX, INC · Georgia · 2nd Quarter 2026 (Apr 1 - June 30)
• AMERICAN LUNG ASSOCIATION
  for AMERICAN LUNG ASSOCIATION · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
• EQUIFAX, INC.
  for EQUIFAX, INC · Georgia · 2nd Quarter 2026 (Apr 1 - June 30)
• AMERICAN LUNG ASSOCIATION
  for AMERICAN LUNG ASSOCIATION · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)

Bodies those filers lobbied

• HOUSE OF REPRESENTATIVES
  7 filings
• SENATE
  7 filings
• Food & Drug Administration (FDA)
  6 filings
• Internal Revenue Service (IRS)
  6 filings
• Centers For Disease Control & Prevention (CDC)
  4 filings
• Centers For Medicare and Medicaid Services (CMS)
  4 filings
• Energy, Dept of
  4 filings
• Environmental Protection Agency (EPA)
  4 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.